Literature DB >> 20195726

Organic osmolytes in hyponatremia and ammonia toxicity.

Jessica Heins1, Claudia Zwingmann.   

Abstract

Hyperammonemia (HA) is a major and commonly observed feature of hepatic encephalopathy. Furthermore, hyponatremia is an important pathogenetic factor in patients with hepatic encephalopathy. Both conditions have some features in common, such as the release of organic osmolytes, which might be an adaptive mechanism against cell swelling. However, the consequence of a possible relationship between osmoregulatory response in hyperammonemia and hyponatremia is not completely understood. This review gives a short introduction into the pathogenesis of hepatic encephalopathy and hyponatremia. For a comparison of both pathological events, some basics on cellular osmo- and volume regulation are explained, in particular as the mechanisms involved in the adaption of the cell to volume changes can be different under both pathological conditions. The role of brain glutamine and organic osmolytes in hyponatremia and hyperammonemia and their combination are discussed based on findings in experimental animal models, and finally on data obtained from primary astrocytes in culture. The observations that the decrease of brain organic osmolytes in astrocytes not adequately compensate for an increased intracellular osmolarity caused by glutamine are consistent with results obtained after chronic hyponatremia in rats, in which the release of osmolytes does not protect from ammonia-induced brain edema. Furthermore, a decrease in intracellular osmolarity is attributed both to the release and a reduced de novo synthesis of amino acids.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20195726     DOI: 10.1007/s11011-010-9170-5

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  71 in total

Review 1.  Cellular volume homeostasis.

Authors:  Kevin Strange
Journal:  Adv Physiol Educ       Date:  2004-12       Impact factor: 2.288

2.  Electron microscopic study of brain capillaries in cerebral edema from fulminant hepatic failure.

Authors:  M Kato; R D Hughes; R T Keays; R Williams
Journal:  Hepatology       Date:  1992-06       Impact factor: 17.425

Review 3.  Therapeutic recommendations for management of severe hyponatremia: current concepts on pathogenesis and prevention of neurologic complications.

Authors:  A Soupart; G Decaux
Journal:  Clin Nephrol       Date:  1996-09       Impact factor: 0.975

4.  Incidence and etiology of hyponatremia in an intensive care unit.

Authors:  M V DeVita; M H Gardenswartz; A Konecky; P M Zabetakis
Journal:  Clin Nephrol       Date:  1990-10       Impact factor: 0.975

5.  T2 hyperintensity along the cortico-spinal tract in cirrhosis relates to functional abnormalities.

Authors:  Juan Córdoba; Nuria Raguer; Montserrat Flavià; Víctor Vargas; Carlos Jacas; Juli Alonso; Alex Rovira
Journal:  Hepatology       Date:  2003-10       Impact factor: 17.425

6.  Chronic hyponatremia exacerbates ammonia-induced brain edema in rats after portacaval anastomosis.

Authors:  J Córdoba; J Gottstein; A T Blei
Journal:  J Hepatol       Date:  1998-10       Impact factor: 25.083

7.  Ammonia and related amino acids in the pathogenesis of brain edema in acute ischemic liver failure in rats.

Authors:  M Swain; R F Butterworth; A T Blei
Journal:  Hepatology       Date:  1992-03       Impact factor: 17.425

Review 8.  Treatment of symptomatic hyponatremia.

Authors:  Guy Decaux; Alain Soupart
Journal:  Am J Med Sci       Date:  2003-07       Impact factor: 2.378

9.  Osmotic demyelination syndrome following correction of hyponatremia.

Authors:  R H Sterns; J E Riggs; S S Schochet
Journal:  N Engl J Med       Date:  1986-06-12       Impact factor: 91.245

10.  Chronic ethanol produces increased taurine transport and efflux in cultured astrocytes.

Authors:  Jeffrey W Allen; Lysette A Mutkus; Michael Aschner
Journal:  Neurotoxicology       Date:  2002-12       Impact factor: 4.294

View more
  11 in total

Review 1.  Approach to Hyponatremia in Cirrhosis.

Authors:  Bashar Attar
Journal:  Clin Liver Dis (Hoboken)       Date:  2019-04-30

2.  Correction of hyponatraemia improves cognition, quality of life, and brain oedema in cirrhosis.

Authors:  Vishwadeep Ahluwalia; Douglas M Heuman; George Feldman; James B Wade; Leroy R Thacker; Edith Gavis; HoChong Gilles; Ariel Unser; Melanie B White; Jasmohan S Bajaj
Journal:  J Hepatol       Date:  2014-08-08       Impact factor: 25.083

3.  Enzymatic analysis of α-ketoglutaramate--a biomarker for hyperammonemia.

Authors:  Lenka Halámková; Shay Mailloux; Jan Halámek; Arthur J L Cooper; Evgeny Katz
Journal:  Talanta       Date:  2012-08-24       Impact factor: 6.057

Review 4.  Hyperammonemia in review: pathophysiology, diagnosis, and treatment.

Authors:  Ari Auron; Patrick D Brophy
Journal:  Pediatr Nephrol       Date:  2011-03-23       Impact factor: 3.714

Review 5.  α-Ketoglutaramate: an overlooked metabolite of glutamine and a biomarker for hepatic encephalopathy and inborn errors of the urea cycle.

Authors:  Arthur J L Cooper; Tomiko Kuhara
Journal:  Metab Brain Dis       Date:  2013-11-14       Impact factor: 3.584

6.  Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis.

Authors:  Vishwadeep Ahluwalia; James B Wade; Leroy Thacker; Kenneth A Kraft; Richard K Sterling; R Todd Stravitz; Michael Fuchs; Iliana Bouneva; Puneet Puri; Velimir Luketic; Arun J Sanyal; Hochong Gilles; Douglas M Heuman; Jasmohan S Bajaj
Journal:  J Hepatol       Date:  2013-05-07       Impact factor: 25.083

7.  Primary carnitine deficiency and pivalic acid exposure causing encephalopathy and fatal cardiac events.

Authors:  Jan Rasmussen; Olav W Nielsen; Allan M Lund; Lars Køber; Høgni Djurhuus
Journal:  J Inherit Metab Dis       Date:  2012-05-08       Impact factor: 4.982

Review 8.  Approach and management of dysnatremias in cirrhosis.

Authors:  Mauro Bernardi; Giacomo Zaccherini
Journal:  Hepatol Int       Date:  2018-09-10       Impact factor: 6.047

Review 9.  Hyponatremia in Patients with Cirrhosis of the Liver.

Authors:  Mauro Bernardi; Carmen Serena Ricci; Luca Santi
Journal:  J Clin Med       Date:  2014-12-31       Impact factor: 4.241

10.  MicroRNA-Mediated Metabolic Reprograming in Renal Cancer.

Authors:  Joanna Bogusławska; Piotr Popławski; Saleh Alseekh; Marta Koblowska; Roksana Iwanicka-Nowicka; Beata Rybicka; Hanna Kędzierska; Katarzyna Głuchowska; Karolina Hanusek; Zbigniew Tański; Alisdair R Fernie; Agnieszka Piekiełko-Witkowska
Journal:  Cancers (Basel)       Date:  2019-11-20       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.